Dentsply Sirona Maintains Outlook Despite Sales Decline Dentsply Sirona Inc. (NASDAQ:XRAY) shares are trading lower on Thursday. Benzinga · Aug 7, 2025
Forecasting The Future: 7 Analyst Projections For Dentsply Sirona In the latest quarter, 7 analysts provided ratings for Dentsply Sirona (NASDAQ:XRAY), showcasing a mix of bullish and bearish perspectives. Benzinga · Dec 4, 2024
Stocks Retreat as Hawkish Fed Comments Push Bond Yields Higher What you need to know… The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.32%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed down -0.67%. Stock indexes on Friday gave up early gains and... Barchart · Jun 16, 2023
Perth team all smiles at new dental hub opening A city centre dental centre serving customers from across Scotland has opened in Perth Daily Record · Aug 24, 2022
What 8 Analyst Ratings Have To Say About Dentsply Sirona Dentsply Sirona (NASDAQ:XRAY) has observed the following analyst ratings within the last quarter: Benzinga · Jun 2, 2022
Why Did Moderna CFO Exit Just A Day After Taking Charge Moderna Inc (NASDAQ:MRNA) announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the company, effective immediately. The announcement follows the public disclosure by Gomez's former employer, Dentsply Sirona Inc (NASDAQ:XRAY), of an ongoing internal investigation into some issues, including financial reporting. The audit investigates Dentsply Sirona's "use of incentives to sell products to… Benzinga · May 11, 2022
What 10 Analyst Ratings Have To Say About Dentsply Sirona Analysts have provided the following ratings for Dentsply Sirona (NASDAQ:XRAY) within the last quarter: Benzinga · May 11, 2022
Dentsply Sirona's Q1 Earnings Miss Street Expectations, Cuts FY22 Guidance Dentsply Sirona Inc's (NASDAQ:XRAY) Q1 FY22 sales decreased 6.1% Y/Y to $965 million, missing the consensus of $988.43 billion. Adjusted EPS decreased to $0.52 from $0.72 a year ago and missed the consensus of $0.56. "The first quarter was a challenging quarter, and our financial performance and revised outlook reflect the impact… Benzinga · May 10, 2022
Recap: Dentsply Sirona Q1 Earnings Dentsply Sirona (NASDAQ:XRAY) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Benzinga · May 10, 2022
Dentsply Sirona Q1 2022 Earnings Conference Call On May 10, 2022 At 08:30 AM ET Dentsply Sirona (NASDAQ:XRAY) will host a conference call at 08:30 AM ET on May 10, 2022, to discuss Q1 2022 earnings results. Benzinga · May 5, 2022
Dentsply Sirona Earnings Conference Call Is Coming Up, Here's What You Need To Know Dentsply Sirona (NASDAQ:XRAY) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Dentsply Sirona (XRAY) Conference Call Follow this link to access the live webcast. Benzinga · May 3, 2022
Expert Ratings for Dentsply Sirona Over the past 3 months, 7 analysts have published their opinion on Dentsply Sirona (NASDAQ:XRAY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. Benzinga · Apr 20, 2022
Benzinga · Apr 19, 2022 Why Are Dentsply Sirona Shares Plummeting Today? Dentsply Sirona Inc (NASDAQ:XRAY) appointed John Groetelaars, who serves on Dentsply Sirona's Board of Directors, as Interim Chief Executive Officer. He succeeds Don Casey, who has been terminated as CEO, and will cease to serve as a member of the Company's Board, effective immediately. The Board has initiated a search to identify…
Benzinga · Mar 1, 2022 What 4 Analyst Ratings Have To Say About Dentsply Sirona Within the last quarter, Dentsply Sirona (NASDAQ:XRAY) has observed the following analyst ratings:
Benzinga · Mar 1, 2022 Dentsply Sirona's Return On Capital Employed Overview According to Benzinga Pro data Dentsply Sirona (NASDAQ:XRAY) posted a 0.97% decrease in earnings from Q3. Sales, however, increased by 1.78% over the previous quarter to $1.09 billion.
Benzinga · Feb 28, 2022 Dentsply Sirona's Q4 Falls Short Of Expectations, FY22 Sales Outlook Lags Street View Dentsply Sirona Inc's (NASDAQ: XRAY)